Biopolymers play a pivotal role in the pharmaceutical field, offering innovative solutions and addressing key challenges in drug delivery, tissue engineering, and biomedical applications. These natural or synthetic polymers derived from living organisms exhibit remarkable biocompatibility and biodegradability, making them ideal candidates for various pharmaceutical formulations. Biopolymers such as chitosan, alginate, and hyaluronic acid have gained prominence due to their unique properties, including mucoadhesion, controlled release, and the ability to enhance drug stability.
In drug delivery systems, biopolymers contribute to sustained drug release, improving therapeutic efficacy while minimizing adverse effects. Moreover, biopolymer-based scaffolds are employed in tissue engineering to support cell growth and tissue regeneration. Their versatility extends to applications like wound healing and surgical implants. The use of biopolymers aligns with the growing emphasis on sustainable and eco-friendly practices in the pharmaceutical industry. As research in biopolymer science advances, the development of novel formulations and delivery systems continues to shape the future of drug development, offering safer and more effective solutions for patient care.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia